Bokemeyer C - Search Results

1

Quinone-carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: synthesis and determination of in vitro activity.

Pelageev DN, Dyshlovoy SA, Pokhilo ND, Denisenko VA, Borisova KL, Keller-von Amsberg G, Bokemeyer C, Fedorov SN, Honecker F, Anufriev VP. Pelageev DN, et al. Among authors: bokemeyer c. Eur J Med Chem. 2014 Apr 22;77:139-44. doi: 10.1016/j.ejmech.2014.03.006. Epub 2014 Mar 5. Eur J Med Chem. 2014. PMID: 24631733

2

Colorectal cancer in the elderly: is palliative chemotherapy of value?

Honecker F, Köhne CH, Bokemeyer C. Honecker F, et al. Among authors: bokemeyer c. Drugs Aging. 2003;20(1):1-11. doi: 10.2165/00002512-200320010-00001. Drugs Aging. 2003. PMID: 12513112 Review.

3

Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors.

Mayer F, Honecker F, Looijenga LH, Bokemeyer C. Mayer F, et al. Among authors: bokemeyer c. Ann Oncol. 2003 Jun;14(6):825-32. doi: 10.1093/annonc/mdg242. Ann Oncol. 2003. PMID: 12796018 Free article. Review.

4

Xeroderma pigmentosum group a protein and chemotherapy resistance in human germ cell tumors.

Honecker F, Mayer F, Stoop H, Oosterhuis JW, Koch S, Bokemeyer C, Looijenga LH. Honecker F, et al. Among authors: bokemeyer c. Lab Invest. 2003 Oct;83(10):1489-95. doi: 10.1097/01.lab.0000090221.95883.41. Lab Invest. 2003. PMID: 14563950 Free article.

5

Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro.

Koch S, Mayer F, Honecker F, Schittenhelm M, Bokemeyer C. Koch S, et al. Among authors: bokemeyer c. Br J Cancer. 2003 Dec 1;89(11):2133-9. doi: 10.1038/sj.bjc.6601375. Br J Cancer. 2003. PMID: 14647149 Free PMC article.

6

[Chemotherapy of advanced colorectal carcinoma: treatment options for elderly patients].

Bokemeyer C, Honecker F. Bokemeyer C, et al. Onkologie. 2003 Dec;26 Suppl 7:48-53. doi: 10.1159/000076175. Onkologie. 2003. PMID: 14716143 Review. German.

7

A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC).

Kollmannsberger C, Schittenhelm M, Honecker F, Tillner J, Weber D, Oechsle K, Kanz L, Bokemeyer C. Kollmannsberger C, et al. Among authors: bokemeyer c. Ann Oncol. 2006 Jun;17(6):1007-13. doi: 10.1093/annonc/mdl042. Epub 2006 Mar 13. Ann Oncol. 2006. PMID: 16533873 Free article. Clinical Trial.

8

Safe use of oxaliplatin in a patient with metastatic breast cancer and combined renal and hepatic failure.

Honecker FU, Brümmendorf TH, Klein O, Bokemeyer C. Honecker FU, et al. Among authors: bokemeyer c. Onkologie. 2006 Jun;29(6):273-5. doi: 10.1159/000093032. Onkologie. 2006. PMID: 16783902

9

Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.

Mueller S, Schittenhelm M, Honecker F, Malenke E, Lauber K, Wesselborg S, Hartmann JT, Bokemeyer C, Mayer F. Mueller S, et al. Among authors: bokemeyer c. Int J Oncol. 2006 Aug;29(2):471-9. Int J Oncol. 2006. PMID: 16820891

10

Treatment of germ cell tumors--update 2006.

Kollmannsberger C, Honecker F, Bokemeyer C. Kollmannsberger C, et al. Among authors: bokemeyer c. Ann Oncol. 2006 Sep;17 Suppl 10:x31-5. doi: 10.1093/annonc/mdl232. Ann Oncol. 2006. PMID: 17018745 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

936 results

Search Page